BioTICfinder: Second-generation diagnostic and therapeutic solutions for SARS-CoV-2

Analysis and development of second-generation diagnostic and therapeutic solutions against SARS-CoV-2 through the combination of biomolecular and digital technologies

The BioTICfinder project aims to develop new diagnostic and therapeutic solutions through the multidisciplinary incorporation of various digital, molecular and biochemical technologies that would allow to create second-generation tools to fight the COVID-19 pandemic. The consortium is comprised by the companies Lincbiotech, Televes, and GalChimia, as well as the University of Santiago de Compostela.

This project has been subsidized by the Galician Innovation Agency (GAIN), through the Conecta COVID Program – European Union Response to the COVID-19 pandemic. This operation is co-financed by the European Union through the European Regional Development Fund (ERDF) within Thematic Objective 1, “Promote research, technological development and innovation”, included in the framework of the ERDF Galicia 2014-2020 Operational Program: A way to make Europe. Total project budget: €981,178.